eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | acute pancreatitis |
| Comorbidity | C0011847|diabetes |
| Sentences | 17 |
| PubMedID- 21180276 | Of all the 12 patients with ipmn, 9 (75.0%) had experienced some symptoms of epigastric discomfort and/or pain as well as backache; 7 cases were with medical history of acute pancreatitis, 5 cases with diabetes, 4 cases with elevated ca19-9, and 2 cases with steatorrhea. |
| PubMedID- 23300896 | Background: increased risks of acute pancreatitis in patients with type 2 diabetes mellitus have been reported recently in several countries. |
| PubMedID- 20833867 | The results of this study confirm the excess risk of acute pancreatitis associated with type 2 diabetes previously reported in other observational studies (2,4,5). |
| PubMedID- 21437074 | This is difficult to establish because there is a generalized increased risk of acute pancreatitis in patients with diabetes, obesity or hyperlipemia. |
| PubMedID- 20682680 | Figure 1 shows the kaplan-meier curve of time to acute pancreatitis in patients with diabetes compared with that in nondiabetic control patients. |
| PubMedID- 24764569 | As incretin based drugs are typically second to third line drugs2 and the risk of acute pancreatitis increases with type 2 diabetes and possibly with duration of disease,404142 it is imperative that they are compared with drugs used at the same or a similar stage of diabetes, otherwise this would introduce a time lag bias.43 it is for this reason that our primary comparator group consisted of sulfonylurea users, which we believe is the clinically most appropriate comparator. |
| PubMedID- 25937079 | Background: there is limited data on the prevalence of coexistent diabetes in acute pancreatitis and subsequent natural history in these patients. |
| PubMedID- 21525466 | Up-to-date observational reports and clinical study data revealed that 44 cases of acute pancreatitis occurred in patients with type 2 diabetes while taking exenatide (8 cases during clinical development and 36 postmarketing reports), 4 cases of pancreatitis in liraglutide-treated patients (in clinical trials), and none during therapy with albiglutide or taspoglutide (51). |
| PubMedID- 24651798 | That study used a large insurance database of more than 1 million people, and reported increased odds of hospitalizations for acute pancreatitis in patients with type 2 diabetes 64 years of age or younger that were prescribed either exenatide or saxagliptin. |
| PubMedID- 19703814 | Objective: to report acute pancreatitis in a patient with non-insulin-dependent diabetes mellitus (niddm) receiving exenatide and critically review previous reports. |
| PubMedID- 22230860 | We are reporting a case of dengue hemorrhagic fever complicated by acute pancreatitis in a patient with history of diabetes mellitus type 1 and end stage renal disease on hemodialysis. |
| PubMedID- 26512613 | To investigate the effects of dipeptidyl peptidase-4 (dpp-4) inhibitors on the risk of acute pancreatitis in patients with type 2 diabetes.this nationwide population-based cohort study used the diabetes patients dataset of taiwan's national health research insurance research database. |
| PubMedID- 21988175 | Conclusions: hba1c may be a useful marker to identify unrecognised diabetes in patients with acute pancreatitis; this group of patients has a higher in hospital mortality. |
| PubMedID- 20412332 | Recent case reports of acute pancreatitis in patients with type 2 diabetes (t2dm) treated with incretin-based therapies have triggered interest regarding the possibility of a mechanism-based association between pancreatitis and glucagon-like peptide-1 mimetics or dipeptidyl peptidase-4 (dpp-4) inhibitors. |
| PubMedID- 24859164 | acute pancreatitis in patients with type 2 diabetes mellitus treated with dipeptidyl peptidase-4 inhibitors: a population-based nested case-control study. |
| PubMedID- 21577242 | Objectives: the objective of this study was to assess the risk of acute pancreatitis among patients with type 2 diabetes mellitus (dm) and identify the roles of co-morbidities and anti-diabetic drugs. |
| PubMedID- 22687379 | Background: the co-existence of diabetes mellitus (dm) in patients with acute pancreatitis (ap) is linked to poor outcomes. |
Page: 1